NVS: Novartis AG Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NVS: Novartis AG

NVS 138.54

+0.5%

Jan 2 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: STEVE who wrote (54)	6/4/2001 12:54:48 PM
From: Night Writer	of 116

OF INTEREST: Bristol-Myers, Novartis leading bidders for DuPont unit, says report New York, June 4 (BridgeNews) - Bristol-Myers Squibb Co. (BMY) and Novartis AG (NVSVF) are among the front runners for DuPont Co.'s (DD) pharmaceuticals business, the Wall Street Journal's online edition reported. The auction is expected to fetch over $6 billion. Anglo-Swedish drug concern AstraZeneca PLC (GB;AZN) may also be in the running for the DuPont business, the report said. ( Story .10677 )

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next